MedTrace Logo

Latent Tuberculosis Infection in Cancer Patients

NCT00507754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2011-09-26

No results posted yet for this study

Summary

Primary Objective:

1\. To evaluate the performance of the new T-SPOT.TB test and the conventional TST for screening of Latent Tuberculosis infections in patients with cancer and those undergoing Hematopoietic Stem Cell Transplant.

Secondary Objectives:

1. To examine the factors associated with positive response to T-SPOT.TB and the TST (tuberculin skin test) in patients with anergy.
2. To determine the impact of immunosuppressive and antineoplastic therapy on the screening performance of T-SPOT.TB and the TST in cancer patients.

Conditions

Interventions

OTHER

T-SPOT TB test

Extra blood draw, followed by ten minutes rest and the injection of Tuberculin subcutaneously on forearm.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Amar Safdar, MD · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507754 on ClinicalTrials.gov